ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 324 filers reported holding ARRAY BIOPHARMA INC in Q2 2019. The put-call ratio across all filers is 1.86 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $7,286,000 | +125.2% | 298,838 | +31.6% | 0.15% | +110.0% |
| Q4 2018 | $3,235,000 | +19.2% | 227,078 | +27.1% | 0.07% | +45.8% |
| Q3 2018 | $2,715,000 | -10.5% | 178,599 | -1.2% | 0.05% | -7.7% |
| Q2 2018 | $3,032,000 | -7.4% | 180,757 | -9.9% | 0.05% | -7.1% |
| Q1 2018 | $3,273,000 | +495.1% | 200,581 | +7.8% | 0.06% | +229.4% |
| Q1 2016 | $550,000 | -27.0% | 186,123 | +4.1% | 0.02% | -19.0% |
| Q4 2015 | $753,000 | – | 178,748 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 9,719,589 | $60,456,000 | 10.40% |
| KOPP INVESTMENT ADVISORS LLC | 2,808,537 | $17,470,000 | 6.42% |
| Redmile Group, LLC | 3,669,593 | $22,825,000 | 3.44% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 10,585,406 | $65,841,000 | 3.06% |
| QVT Financial LP | 2,878,600 | $17,905,000 | 1.22% |
| APEX CAPITAL, LLC | 2,500,000 | $15,550,000 | 1.12% |
| FBR & Co. | 113,500 | $706,000 | 1.07% |
| Artal Group S.A. | 3,000,000 | $18,660,000 | 0.61% |
| Perimeter Capital Partners, LLC | 486,478 | $3,026,000 | 0.56% |
| Orbimed Advisors | 4,831,600 | $30,053,000 | 0.54% |